These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19443681)

  • 1. The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.
    Schwartz J; Hunt T; Smith WB; Wong P; Larson P; Crumley T; Mehta A; Gottesdiener K; Agrawal N
    J Clin Pharmacol; 2009 Jul; 49(7):807-15. PubMed ID: 19443681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy women.
    Kasserra C; Li J; March B; O'Mara E
    Clin Ther; 2011 Oct; 33(10):1503-14. PubMed ID: 22015327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers.
    Shadle CR; Liu G; Goldberg MR
    J Clin Pharmacol; 2000 Mar; 40(3):309-15. PubMed ID: 10709161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects.
    Doose DR; Wang SS; Padmanabhan M; Schwabe S; Jacobs D; Bialer M
    Epilepsia; 2003 Apr; 44(4):540-9. PubMed ID: 12681003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for a new triphasic oral contraceptive.
    Pasquale SA
    Int J Fertil; 1986; 31 SU [UPDATE]():13-9. PubMed ID: 2899554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of interaction between fluconazole and an oral contraceptive in healthy women.
    Hilbert J; Messig M; Kuye O; Friedman H
    Obstet Gynecol; 2001 Aug; 98(2):218-23. PubMed ID: 11506836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.
    Lin WH; Feng HP; Shadle CR; O'Reilly T; Wagner JA; Butterton JR
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1107-13. PubMed ID: 24992979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre study.
    Spence R; Mandagere A; Walker G; Dufton C; Boinpally R
    Clin Drug Investig; 2010; 30(5):313-24. PubMed ID: 20384387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug-Drug Interaction Study in Healthy Females.
    Landry I; Aluri J; Hall N; Filippov G; Dayal S; Moline M; Reyderman L
    Clin Pharmacol Drug Dev; 2021 Sep; 10(9):1089-1098. PubMed ID: 34107159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers.
    Inglis AM; Miller AK; Culkin KT; Finnerty D; Patterson SD; Jorkasky DK; Freed MI
    J Clin Pharmacol; 2001 Jun; 41(6):683-90. PubMed ID: 11402638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir.
    Garg V; van Heeswijk R; Yang Y; Kauffman R; Smith F; Adda N
    J Clin Pharmacol; 2012 Oct; 52(10):1574-83. PubMed ID: 22039291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers.
    Agrawal NG; Porras AG; Matthews CZ; Woolf EJ; Miller JL; Mukhopadhyay S; Neu DC; Gottesdiener KM
    J Clin Pharmacol; 2001 Oct; 41(10):1106-10. PubMed ID: 11583479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rofecoxib on the pharmacokinetics of chronically administered oral contraceptives in healthy female volunteers.
    Schwartz JI; Wong PH; Porras AG; Ebel DL; Hunt TR; Gertz BJ
    J Clin Pharmacol; 2002 Feb; 42(2):215-21. PubMed ID: 11831545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.
    LoRusso PM; Piha-Paul SA; Mita M; Colevas AD; Malhi V; Colburn D; Yin M; Low JA; Graham RA
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):193-202. PubMed ID: 23064958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
    Shoupe D
    Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man.
    Agrawal NG; Porras AG; Matthews CZ; Rose MJ; Woolf EJ; Musser BJ; Dynder AL; Mazina KE; Lasseter KC; Hunt TL; Schwartz JI; McCrea JB; Gottesdiener KM
    J Clin Pharmacol; 2003 Mar; 43(3):268-76. PubMed ID: 12638395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.
    Schwartz JI; Agrawal NG; Wehling M; Musser BJ; Gumbs CP; Michiels N; De Smet M; Wagner JA
    Br J Clin Pharmacol; 2008 Dec; 66(6):811-7. PubMed ID: 18823299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of three bioequivalent norethindrone/mestranol-50 micrograms and three norethindrone/ethinyl estradiol-35 micrograms OC formulations: are "low-dose" pills really lower?
    Brody SA; Turkes A; Goldzieher JW
    Contraception; 1989 Sep; 40(3):269-84. PubMed ID: 2766722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.